75259-30-2 Usage
Physical Properties
Clear, colorless, and odorless liquid
Medical Use
Prevention of hemorrhagic cystitis, a side effect of certain cancer treatments
Mechanism of Action
Detoxifies acrolein, a toxic metabolite of cancer drugs, and prevents its harmful effects on the bladder
Administration
Intravenous or oral
Chemical Groups
Contains a sulfhydryl group that reacts with acrolein
Excretion
Forms a stable compound that can be excreted harmlessly from the body
Safety and Tolerability
Generally well-tolerated with relatively few side effects
Importance
Considered an important supportive therapy in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 75259-30-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,2,5 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 75259-30:
(7*7)+(6*5)+(5*2)+(4*5)+(3*9)+(2*3)+(1*0)=142
142 % 10 = 2
So 75259-30-2 is a valid CAS Registry Number.
75259-30-2Relevant academic research and scientific papers
FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
-
, (2016/12/22)
The present invention relates broadly to functionalised and substituted indoles, the preparation thereof and their use in the treatment of proliferative diseases such as cancer.
DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS
-
Page/Page column 64, (2010/07/04)
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.
